Follow The Filings

VCYT Veracyte

Veracyte earnings company data as of 10:27 PM ET 11/12

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.28 0.51 Beat +82.1%
Rev $147.1M $151.8M Beat +3.2%

Insider trades

Open-market buys and sales by VCYT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VCYT insider trades
  • None no insider bought on the open market
  • $1.1M sold by 1 insider outside a trading plan
  • $17.7M sold by 10 insiders under 10b5-1 plans
  1. Jens Holstein Director
    Planned sale
    $728K 15,000 shares at $48.50 35% of stake
    Traded Sep 24–Oct 27 Filed Oct 28
  2. Karin Eastham Director
    Planned sale
    $743K 14,850 shares at $50.00 59% of stake
    Traded Oct 27 Filed Oct 28
  3. Muna Bhanji Director
    Planned sale
    $81K 1,864 shares at $43.70 4.4% of stake
    Traded Oct 19 Filed Oct 20
  4. John Leite Global Chief Commercial Off
    Planned sale
    $161K 4,015 shares at $40.00 3.1% of stake
    Traded Sep 21 Filed Sep 22
  5. Jens Holstein Director
    Planned sale
    $205K 5,000 shares at $40.95 15% of stake
    Traded Sep 14 Filed Sep 16
  6. Annie McGuire EVP, General Counsel
    Planned sale
    $140K 3,254 shares at $43.09 2.4% of stake
    Traded Sep 4 Filed Sep 4
  7. Rebecca Chambers CFO
    Planned sale
    $157K 3,652 shares at $43.10 2.2% of stake
    Traded Sep 4 Filed Sep 4
  8. Phillip G. Febbo Chief Scientific & Med Officer
    Planned sale
    $564K 13,110 shares at $43.05 9% of stake
    Traded Sep 4 Filed Sep 4
  9. Muna Bhanji Director
    Planned sale
    $80K 1,864 shares at $42.97 4.2% of stake
    Traded Sep 1 Filed Sep 3
  10. Karin Eastham Director
    Planned sale
    $197K 3,729 shares at $52.89 20% of stake
    Traded Jun 18 Filed Jun 22
  11. John Leite Global Chief Commercial Off
    Planned sale
    $700K 13,975 shares at $50.07 9.6% of stake
    Traded Jun 4 Filed Jun 4
  12. Annie McGuire EVP, General Counsel
    Planned sale
    $158K 3,176 shares at $49.76 2.3% of stake
    Traded Jun 4 Filed Jun 4
  13. Rebecca Chambers CFO
    Planned sale
    $177K 3,561 shares at $49.73 2% of stake
    Traded Jun 4 Filed Jun 4
  14. Marc Stapley CEO
    Planned sale
    $6.9M 138,051 shares at $50.12 24% of stake
    Traded Jun 4 Filed Jun 4
  15. Jonathan Wygant VP, Chief Accounting Officer
    Sale
    $1.1M 24,000 shares at $45.40 35% of stake
    Traded May 22 Filed May 27

Also filed in the last 12 months, not counted as buying or selling: 30 share withholdings for taxes, 24 stock grants, and 7 option exercises.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,8.01,9.01
8-K 1.01,2.01,7.01,9.01
10-Q
8-K 2.02,9.01
8-K 5.02,5.07
SCHEDULE 13G/A —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf